BERNARD LOPEZ: Open Payments
NPI 1568458891 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 28 payments from 10 companies in 2025. Trend: 2023 $354 · 2024 $530 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $97 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Corium, LLC | 4 | $68 |
| Alkermes, Inc. | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Neos Therapeutics, LP | 3 | $42 |
| Tris Pharma Inc | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, Azstarys, ARISTADA, COBENFY, Adzenys XR-ODT, Dyanavel XR, REXULTI.
Industry payments across FL — which companies pay providers there.
